| Net Cash Provided by (Used in) Operating Activities |
$350,852,449 |
USD |
-45% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$345,332,216 |
USD |
42% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares, Issued |
46,059,314 |
shares |
76% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$39,940,602 |
USD |
68% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$9,475,576 |
USD |
243% |
Q1 2025 |
Q1 2025 |
| Deferred Income Tax Expense (Benefit) |
$100,000 |
USD |
-50% |
Q3 2025 |
Q3 2025 |
| Current Income Tax Expense (Benefit) |
$100,000 |
USD |
0% |
Q3 2025 |
Q3 2025 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
$1,176,094,307 |
USD |
76% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
$42,745,319 |
USD |
311% |
Q2 2025 |
Q2 2025 |